H5N1 avian influenza vaccine intranasal - MedImmune/NIAID

Drug Profile

H5N1 avian influenza vaccine intranasal - MedImmune/NIAID

Alternative Names: Avian flu vaccine - MedImmune/NIAID; H5N1 influenza vaccine - MedImmune/NIAID; MEDI-550; MEDI-566; Pandemic influenza vaccine - MedImmune/NIAID

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator MedImmune Vaccines; National Institute of Allergy and Infectious Diseases
  • Developer MedImmune Vaccines
  • Class Influenza A virus H5N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Influenza A virus H5N1 subtype

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype(Prevention) in USA (Intranasal)
  • 01 Apr 2016 The Committee for Medicinal Products for Human Use recommends approval of Influenza-A virus H5N1 subtype vaccine for Influenza-A virus H5N1 subtype (Prevention) in European Union (Intranasal)
  • 31 Dec 2015 Preregistration for Influenza-A virus H5N1 subtype(Prevention) in European Union (Intranasal) (AstraZeneca's pipeline, February 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top